anti-ROR1 CAR macrophage therapy (Factor Bioscience)

N/A

Report date: 2025/03/18 18:09:58

Base Information

Drug Nameanti-ROR1 CAR macrophage therapy (Factor Bioscience)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 modulators

TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1

Therapy Area/IndicationsNeoplasmsCommunicable Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFactor Bioscience Inc

China Registration ClassN/A

Develop Information

Active CompaniesFactor Bioscience Inc

Inactive CompaniesN/A

Active IndicationsNeoplasmsCommunicable Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A